CK Life Sciences accelerates China entry for cancer vaccine pipeline through fast track clinical strategy

CK Life Sciences accelerates China entry for cancer vaccine pipeline through fast track clinical strategy

  • March 30, 2026

Hong Kong based CK Life Sciences is preparing to advance its cancer vaccine pipeline into mainland China using a faster clinical development pathway as the country expands support for early stage drug innovation. Backed by the business empire of Li Ka-shing, the company

MindRank Reaches Phase 3 Trials With China’s First AI Assisted New Drug, Slashing R&D Costs

MindRank Reaches Phase 3 Trials With China’s First AI Assisted New Drug, Slashing R&D Costs

  • January 5, 2026

A milestone moment for AI driven drug development China’s biotech sector has reached a landmark moment as Hangzhou based start-up MindRank advanced its weight loss drug into Phase 3 clinical trials. The development marks the first time a Category 1 new drug in